Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.75 USD | +4.61% | +18.91% | -13.11% |
26/04 | Belite Bio Unveils Plan to Offer 651,380 American Depository Shares | MT |
22/03 | Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan | MT |
Business Summary
Number of employees: 20
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 27/18/27 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 01/20/01 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/21/01 |
Jennifer Wu
IRC | Investor Relations Contact | - | - |
Ching Chen Chiu
PRN | Corporate Officer/Principal | 55 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 01/22/01 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 01/22/01 |
John Longo
BRD | Director/Board Member | 55 | 01/22/01 |
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 27/18/27 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 01/20/01 |
Hung Wei Chen
BRD | Director/Board Member | 43 | 01/21/01 |
Wan Shan Chen
BRD | Director/Board Member | 38 | 01/21/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,149,444 | 11,377,027 ( 39.03 %) | 0 | 19.31 % |
Stock B | 1 | 29,754,122 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.11% | 1.16B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BLTE Stock
- Company Belite Bio, Inc